SINTX Technologies to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025

Core Viewpoint - SINTX Technologies, Inc. has been invited to present at the H.C. Wainwright 27th Annual Global Investment Conference, highlighting its growth strategy and recent financial initiatives aimed at accelerating its strategic objectives [1][3]. Group 1: Conference Participation - The conference is scheduled from September 8–10, 2025, at the Lotte New York Palace Hotel, with SINTX's presentation set for September 9, 2025 [1]. - The event serves as a platform for the company to share its objectives, progress, and engage with institutional investors [2]. Group 2: Company Strategy and Objectives - SINTX plans to outline its growth strategy, near-term milestones, and the impact of its silicon nitride platform in medical device and infection-prevention markets [3]. - Recent financial initiatives, including a warrant inducement plan, are expected to enhance the company's ability to pursue its strategic objectives [3]. Group 3: Company Overview - SINTX Technologies, based in Salt Lake City, Utah, specializes in advanced ceramics for biomedical applications, particularly silicon nitride [5]. - The company has been a leader in the research, development, and manufacturing of silicon nitride, with products implanted in humans since 2008 [5]. - SINTX continues to expand its portfolio through innovation and strategic partnerships across multiple markets [5].